Zygomycetes cause serious invasive infections, predominantly in immunocompromised and diabetic patients with poor prognoses and limited therapeutic options. We compared the antifungal function of human polymorphonuclear leukocytes (PMNLs) against hyphae of Rhizopus oryzae and R. microsporus, the most frequently isolated zygomycetes, with that against the less frequently isolated Absidia corymbifera. We then evaluated the effects of interferon (IFN)-g and granulocyte-macrophage colony-stimulating factor (GM-CSF), alone or combined, on PMNL antifungal function against these zygomycetes. Both PMNL oxidative burst in response to hyphae and PMNL-induced hyphal damage were significantly lower in response to Rhizopus species than in response to A. corymbifera. Incubation of PMNLs with IFN-g and GM-CSF alone or combined for 22 h increased the PMNL-induced hyphal damage of all 3 species. The treatment of PMNLs with the combination of IFN-g and GM-CSF significantly increased the release of tumor necrosis factor-a in response to R. microsporus and A. corymbifera hyphae. IFN-g significantly reduced interleukin-8 release in response to all zygomycetes. Although Rhizopus species demonstrate a decreased susceptibility to the antifungal activity of human PMNLs, in comparison with A. corymbifera, IFN-g and GM-CSF augment the hyphal damage of all 3 zygomycetes, suggesting a role for IFN-g and GM-CSF in the management of invasive zygomycosis.
those with diabetes mellitus [1] [2] [3] [4] . Deferoxamine, cystic fibrosis, and malnutrition also have been observed as less frequent underlying diseases in patients with zygomycosis. Zygomycetes cause rhinocerebral, pulmonary, disseminated, cutaneous, and gastrointestinal forms of infection, as a result of angioinvasion, thrombosis, infarction, and necrosis of involved tissues [1, 2, 5] .
Members of the genus Rhizopus-in particular, R. oryzae and R. microsporus-are the most common organisms isolated from patients with zygomycosis. By comparison, other species of the class Zygomycetes, such as Absidia corymbifera, rarely cause deeply invasive infections [6] [7] [8] . The biological basis for these differences in frequency of infection is unknown but may involve differences in host response to different genera or differences in zygomycete response to different hosts. Early studies of human host defenses against R. oryzae underscored the importance of intact innate immuni-ty, including functional polymorphonuclear leukocytes (PMNLs) [9] [10] [11] [12] [13] . Both oxidative and nonoxidative mechanisms appear to be critical in the process of antifungal PMNL activity [14] [15] [16] [17] . Neutropenia or functional deficiency of PMNLs are the main risk factors for the development of zygomycosis [1] [2] [3] [4] .
Cytokines are a critical component of functional innate antifungal host defenses. In particular, interferon-g (IFN-g) and granulocyte-macrophage colony-stimulating factor (GM-CSF), 2 clinically important therapeutic agents [18] , augment the antifungal activity of PMNLs against Aspergillus fumigatus [19] [20] [21] . However, zygomycetes are members of a different taxonomic class of fungi, with many pathogenic features that are distinct from those of Aspergillus species, and little is known about the immunomodulatory activity of cytokines in augmenting host defenses against zygomycetes. In addition, GM-CSF stimulates the production of phagocytes and inhibits PMNL apoptosis [22] [23] [24] [25] , thus increasing the number of functional PMNLs [23] . Interleukin-8 (IL-8) and tumor necrosis factora (TNF-a) are well-known cytokines that strongly prime the oxidative burst of PMNLs in response to N-formyl peptides and, thus, could potentially play a critical role in fungal killing [26] . IL-8 also plays a critical role as a chemokine in recruiting PMNLs to foci of infection [27] . However, little is known about the immunoregulation of TNF-a and IL-8 in the innate host response to zygomycetes.
We therefore evaluated the antifungal activities of PMNLs against the most frequently isolated zygomycetes, R. oryzae and R. microsporus, alone or after treatment with IFN-g and GM-CSF and compared these functions with those against the relatively uncommon species, A. corymbifera. Among the antifungal PMNL activities that we investigated were oxidative burst, hyphal damage, and release of IL-8 and TNF-a in response to hyphae of the 3 zygomycetes.
MATERIALS AND METHODS

PMNL isolation.
PMNLs were isolated from heparinized whole blood of healthy young adult volunteers [19] . Blood was immediately allowed to settle with 3% dextran T500 (Pharmacia Biotech AB) in a 2:1 volume/volume proportion. PMNLs were separated by centrifugation over a ficoll (Lymphocyte Separation Medium, Gibco BRL Life Technologies) cushion. Contaminating erythrocytes were hypotonically lysed, and the PMNL suspension was washed in Hanks' balanced salt solution without Ca 2+ and Mg 2+ (HBSS Ϫ ; Gibco). The cells were resuspended in HBSS Ϫ and counted on a hemocytometer.
Cytokine treatment.
PMNLs were incubated at a concentration of cells/mL in RPMI 1640 supplemented with 6 5 ϫ 10 10% pooled human serum (in the case of 2-h incubation) or 10% autologous serum (in the case of 22-h incubation) in the presence or absence of 100 ng/mL IFN-g (Boehringer-Ingelheim) and/or 100 ng/mL GM-CSF (Schering-Plough; donated by Tore Abrahamsen, University of Oslo, Oslo, Norway), at 37ЊC and 5% CO 2 . At the end of the 22-h incubation, PMNLs were counted using a hemocytometer, and the viability was assessed with trypan blue staining, ensuring 195% viability.
Fungi. Three clinical isolates of zygomycetes were used in these studies. R. oryzae (RO 27) was isolated from a cut-down wound site (Fungus Testing Laboratory, University of Texas Health Sciences Center, San Antonio), R. microsporus var. rhizopodiformis (AZN 1185) was isolated from an invasive infection, and A. corymbifera (AZN 4095 and CBS 271.65) was a clinical isolate from an undetermined site of infection. The 2 latter isolates were donated by Paul Verweij (University Medical Center St. Radboud, Neijmegen, The Netherlands).
Fungi from frozen stocks were inoculated on potato dextrose agar (Merck Darmstadt) plates and grown for 4 days. Sporangiospores were then harvested by scraping the surfaces of the plates, suspended in HBSS Ϫ , and filtered through sterile gauze.
After centrifugation at 400 g for 10 min, supernatant was aspirated, the pellet was resuspended in normal saline, and cells were counted on a hemocytometer. They were kept at 4ЊC for no longer than 3 weeks. Hyphae were generated for each of the fungi by placing 200 mL c from horse heart (Sigma Chemical Co.) [28] . Hyphae were prepared as described above. Once the hyphal network was established, in the case of O 2 Ϫ assays with serum-opsonized hyphae, the plate was centrifuged at 400 g at 25ЊC for 30 min. YNB was then replaced by 50% human serum in HBSS Ϫ , and the plate was rotated at 37ЊC for 30 min, for opsonization. Because zygomycete hyphae were loosely attached to the bottom of the wells, plates were always centrifuged before aspiration of supernatant during washing. The plate was washed 3 times, and PMNLs were added at an effector cell:target (E:T) ratio of 1:1 to a final volume of 200 mL of HBSS Ϫ containing 60 mmol/L cytochrome c with serum-opsonized or nonopsonized hyphae. Basal O 2 Ϫ production was assessed in the absence of stimuli. After incubation at 37ЊC on a rotator for 1 h, 100 mL was transferred to another plate, and absorbance was read in a spectrophotometer at 550 nm, with a reference of 690 nm. The extinction coefficient of cytochrome c at 550 nm was taken as L/mol7cm. Hyphal damage assay. PMNL-induced hyphal damage was assessed by use of a modification of the XTT (2,3-bis[2-methoxy-4-nitro-5-sulfophenyl]2H-tetrazolium-5-carboxanilide sodium salt; Sigma) plus coenzyme Q 0 (2,3-dimethoxy-5-methyl-1,4-benzoquinone; Sigma) assay [29] . Hyphae were generated as described above. Once the hyphal network was established, the plates were centrifuged at 400 g at 25ЊC for 30 min. YNB in each plate was then replaced by 200 mL of RPMI 1640 supplemented with 10% heat-inactivated fetal calf serum, and PMNLs were added at the corresponding E:T ratios. After incubation at 37ЊC with 5% CO 2 for 2 or 22 h, the plates were centrifuged at 400 g at 10ЊC for 30 min. One hundred ninety microliters of RPMI 1640 was then replaced with H 2 O, and the plates were centrifuged again, to lyse the cells without aspiration of hyphae. After a second wash performed in this manner, H 2 O in each plate was replaced by 150 mL of PBS (Biochrom KG) containing 25 mg/mL XTT and 40 mg/mL coenzyme Q 0 . Aspiration of the wells was performed very gently with a multichannel pipette. Because of the possibility of aspiration of hyphae, wells were set in octuplicate. After incubation with XTT, the wells of the plate were observed under the microscope, to ensure that hyphae were not accidentally aspirated from the wells. After incubation with XTT at 37ЊC with 5% CO 2 for 1 h, 100 mL from each plate was transferred to a new plate, and the change in color (absorbance) was assessed spectrophotometrically at 450 nm by use of a 690-nm reference. Antihyphal activity was calculated according to the following formula: percentage of hyphal damage , where X is the p (1 Ϫ X/C) ϫ 100 absorbance of experimental wells and C is the absorbance of control wells with hyphae only.
Cytokine release from PMNLs. Release of IL-8 and TNFa from IFN-g-and GM-CSF-treated PMNLs was measured by incubating PMNLs for 4 h in microtiter plate wells containing 200 mL of HBSS Ϫ with PMNLs/well. PMNLs 5 1.5 ϫ 10 were added to wells containing hyphae of the 3 zygomycetes (generated from sporangiospores, as described above) at an E :T ratio of 10:1. For baseline release of IL-8 and TNF-a, freshly isolated PMNLs were also incubated for 2 or 22 h without IFNg and GM-CSF. Untreated and treated PMNLs were added at the same E:T ratio to microtiter plate wells containing fungal hyphae and were suspended in HBSS Ϫ at 37ЊC for 4 h. At the end of the incubation period, supernatants were stored at Ϫ20ЊC until testing for IL-8 and TNF-a concentrations. TNFa and IL-8 production was assessed using Quantikine ELISAs (R&D Systems). The sensitivities of the TNF-a and IL-8 assays were !4 and !10 pg/mL, respectively. Statistical analysis. Each experiment was performed with the cells of 1 donor and by use of quadruplicate or octuplicate wells for each condition. The mean value of these replicate wells was taken as the value for this particular donor/experiment. The means of the replicate wells of each experiment were then used in the data analysis to calculate the of mean ‫ע‬ SE all the experiments at the same conditions. The statistics program Instat (version 3.0; Graphpad) was used for analysis. Differences in PMNL response to the zygomycetes were evaluated by repeated-measures analysis of variance (ANOVA) with Bonferroni posttest. Differences in antifungal effects between the cytokine-treated PMNLs and the untreated controls were performed using repeated-measures ANOVA with Dunnett's posttest for multiple comparisons. A 2-sided indicated sta-P ! .05 tistical significance.
RESULTS
O 2
5 production. We evaluated the oxidative burst of PMNLs immediately after their isolation, by use of serum-opsonized or nonopsonized hyphae as stimuli (figure 1 Opsonized hyphae of R. oryzae and R. microsporus stimulated PMNLs to produce higher amounts of O 2 Ϫ than did nonopsonized hyphae of these fungi ( ). A trend of higher O 2 Ϫ P ! .001 production in response to serum-opsonized A. corymbifera hyphae than in response to nonopsonized hyphae also was evident. PMNL-induced hyphal damage. PMNLs induced hyphal damage of each of the 3 species in a E:T ratio-dependent manner, showing a significant linear trend ( ) (figure P ! .005 2). PMNLs damaged hyphae of A. corymbifera to a significantly higher degree than they damaged hyphae of Rhizopus species, at E:T ratios of 5:1 and 10:1 ( ). A similar trend was P ! .001 observed at an E:T ratio of 20:1 ( ). P p .087 Effects of cytokines on PMNL oxidative burst. After incubation for 2 h, IFN-g and GM-CSF alone or combined significantly increased O 2 Ϫ production by PMNLs in response to serum-opsonized hyphae of A. corymbifera ( ) ( figure 3 ). P ! .01 In addition, GM-CSF and its combination with IFN-g augmented PMNL oxidative burst in response to nonopsonized A. corymbifera hyphae ( ). However, only GM-CSF signifi-P ! .01 cantly increased the PMNL oxidative burst in response to nonopsonized hyphae of R. oryzae at 2 h ( ), and no cytokine P ! .01 affected the oxidative burst in response to serum-opsonized hyphae of R. oryzae at 2 h. In the case of R. microsporus, both GM-CSF and its combination with IFN-g augmented the oxidative burst in response to nonopsonized hyphae ( ), P ! .01 whereas only GM-CSF showed an enhancing effect in response to serum-opsonized hyphae ( ). These effects were not P ! .05 evident after incubation for 22 h, since treated PMNLs released amounts of O 2 Ϫ similar to those released by untreated PMNLs.
Effects of cytokines on hyphal damage. PMNLs that had been treated with IFN-g, GM-CSF, or their combination for 22 h exhibited a significantly increased capacity to induce hyphal damage of all 3 zygomycetes (figure 4 The augmenting effects of IFN-g and GM-CSF were time dependent, requiring prolonged incubation of PMNLs with the cytokines. Thus, PMNLs that had been pretreated with IFN-g, GM-CSF, or their combination for only 2 h did not show a significant increase in induction of hyphal damage for any of the 3 species, with the exception of IFN-g-pretreated PMNLs and subsequent challenge with R. microsporus hyphae (P p .027; data not shown).
Effects of cytokines on TNF-a and IL-8 release from PMNLs. After incubation of PMNLs with the combination of IFN-g and GM-CSF for 2 h, TNF-a release from PMNLs in response to R. microsporus and A. corymbifera hyphae was significantly increased, compared with that from untreated PMNLs ( figure  5, upper panel) . Whereas TNF-a release from untreated PMNLs in response to R. microsporus hyphae was pg/mL, 477 ‫ע‬ 89 TNF-a release from PMNLs treated with the combination of IFN-g and GM-CSF was augmented to pg/mL 1222 ‫ע‬ 236 ( ). Similarly, when untreated PMNLs were challenged P ! .05 with A. corymbifera hyphae, TNF-a release was pg/ 392 ‫ע‬ 118 mL, whereas, in the case of PMNLs treated with the combination of IFN-g and GM-CSF, it increased to pg/ 849 ‫ע‬ 286 mL ( ). A significant enhancing effect of the combination P ! .05 of IFN-g and GM-CSF also was observed in response to R. microsporus after 22 h (TNF-a release from untreated PMNLs was pg/mL, vs. pg/mL from PMNLs treated 354 ‫ע‬ 78 905 ‫ע‬ 193 with both cytokines;
), but there was a trend of en-P ! .05 hancement in response to A. corymbifera hyphae ( figure 5, lower  panel) . Comparable amounts of TNF-a were measured in untreated PMNLs and in PMNLs treated with each cytokine alone after 2 or 22 h in response to R. microsporus and A. corymbifera. When PMNLs treated for 2 or 22 h with IFN-g, GM-CSF, or their combination were challenged with R. oryzae hyphae, there was no effect on TNF-a release.
PMNLs treated with IFN-g for 2 h had significantly decreased IL-8 release in response to R. oryzae, R. microsporus, and A. corymbifera hyphae, compared with that of untreated PMNLs ( ) ( figure 6, upper panel) . The suppression of IL-8 release P ! .01 in response to all 3 zygomycetes became even more pronounced after incubation of PMNLs with IFN-g for 22 h ( ) (figure P ! .01 6, lower panel). Treatment of PMNLs with GM-CSF or its combination with IFN-g for 2 or 22 h did not produce a significant effect on IL-8 release in response to any of these 3 zygomycetes; the only exception was GM-CSF treatment of PMNLs for 2 h and stimulation by A. corymbifera.
DISCUSSION
In this study, we have found that human PMNLs have a reduced capacity to mount an oxidative burst in response to both Rhizopus species and to induce hyphal damage of these zygomycetes, in comparison with its response to A. corymbifera. However, IFN-g and GM-CSF augmented PMNL-induced hyphal damage of all 3 zygomycetes, in a time-dependent manner. Furthermore, treatment of PMNLs with the combination of cytokines enhanced the release of TNF-a in response to R. microsporus and A. corymbifera but not in response to R. oryzae hyphae. By comparison, IFN-g inhibited IL-8 release in response to hyphae of the 3 zygomycetes. To our knowledge, this is the first time that intergenus differences in host response to zygomycetes have been reported and that the effects of IFN-g and GM-CSF on PMNL response to these fungi have been described. Despite the long-standing clinical interest in zygomycetes as causative agents of serious and frequently fatal infections in immunocompromised and diabetic patients, little has been accomplished in recent years to improve the understanding of host defenses against zygomycetes and the role of cytokines. Indeed, the antifungal activity of PMNLs and macrophages, as well as the mechanisms involved, were investigated in pioneering studies 2 decades ago [9] [10] [11] [12] [13] . With the exception of 1 study demonstrating the ex vivo effects of granulocyte colonystimulating factor in up-regulating PMNL-induced hyphal damage of R. arrhizus (synonymous with R. oryzae) [30] , no studies have examined the effects of any cytokines on multiple species of zygomycetes.
The finding that both Rhizopus species stimulated PMNL oxidative burst less often than did A. corymbifera and suffered less hyphal damage from PMNLs may be related to the relatively high frequency of Rhizopus species and the comparatively lower frequency of A. corymbifera as causative agents of zygomycosis [1] [2] [3] [4] [5] . These data suggest that reduced susceptibility to innate host defense by members of the genus Rhizopus may contribute to their greater prevalence as pathogens in immunocompromised patients. Differences in cell-wall constituents and ligands on the surface of the hyphae of the different genera of zygomycetes may account for the differences in the stimulation of PMNLs and the susceptibility to their antifungal activity. An alternative explanation that may account for such differences is that organism-related factors (e.g., diffusible components of the fungal surface or production of toxins by Rhizopus hyphae) compromise any effects of PMNLs challenged with that fungus. That soluble factors from R. oryzae may enhance the PMNL respiratory burst was suggested in the study by Liles et al. [30] . Similar to hyphae of other filamentous fungi, such as A. fumigatus, Fusarium species, and Scedosporium species [12, 31, 32] , hyphae of zygomycetes induced an increase in O 2 Ϫ production, compared with nonstimulated PMNLs, and the antihyphal activity induced by PMNLs was E:T ratio dependent.
In this study, we describe-for the first time, to our knowledge-a modification of the XTT assay previously used for the study of hyphal damage of other filamentous fungi [29, [31] [32] [33] , to study PMNL-zygomycete interactions. Since hyphae of zygomycetes adhere to the plastic surface of wells very loosely, we centrifuged the plates before each aspiration and took care to leave a small amount of H 2 O in the wells during the washes. With this modification, XTT, an easily performed nonradioisotopic assay, could be used for the study of hyphal damage of zygomycetes instead of a radioactive assay, which previous investigators were required to use [13] .
IFN-g and GM-CSF are among the cytokines most frequently used for prevention and treatment of invasive fungal infections [18] . This and the fact that they, in theory, have many favorable features for immune up-regulation against zygomycosis prompted us to investigate their activities against these organisms. Indeed, GM-CSF has been found to augment phagocytosis and oxidative burst and to increase the number and membrane expression of several classes of surface receptors on PMNLs, such as FMLP, CD11b, and C3bi [23, 34, 35] . Additionally, GM-CSF increases PMNL fungicidal activity against several pathogenic species of fungi [20, 21, [36] [37] [38] and protects mice in 2 models of deep candidiasis [39, 40] . Similarly, IFN-g induces a Th1 response, which favors resistance to invasive fungal infections [18, 21, 41] . This cytokine primes O 2 Ϫ production of PMNLs in response to FMLP, in a time-dependent manner, by a mechanism that involves synthesis of proteins [42, 43] . Additionally, IFN-g enhances PMNL fungistatic and fungicidal activities against certain fungal pathogens [21, 37, 38, [44] [45] [46] . Administration of this cytokine to experimental animals with fungal infections has yielded encouraging results [47] [48] [49] [50] . In patients with chronic granulomatous disease, IFN-g reduced the risk of infections by a mechanism independent from O 2 Ϫ production [51] , and administration of IFN-g to healthy volunteers improved their phagocytic host defense, indicating that this cytokine may be useful in the treatment of patients with other immune disorders [52] .
We found a time dissociation between augmentation of O 2 Ϫ production and hyphal damage by treatment of PMNLs with IFN-g and GM-CSF. Whereas the optimal time for increase of O 2 Ϫ production was 2 h, the optimal time for increase of hyphal damage was 22 h. This time dependency in response to stimuli, which has previously been noted, to a lesser extent, with other filamentous fungi [53, 54] , may be due to (1) increased amounts of myeloperoxidase or other antifungal proteins, as a result of augmented signal transduction and synthesis of proteins induced by the cytokines; (2) posttranslational processing of these proteins; and/or (3) an increased rate of degranulation of PMNLs releasing antifungal proteins. These data also demonstrate a potentially critical role for nonoxidative mediators (e.g., antimicrobial peptides) in mediating the enhanced PMNL host response to Rhizopus and Absidia species. Indeed, although IFN-g had no effect on O 2 Ϫ production in response to Rhizopus species, it substantially enhanced hyphal damage of all 3 zygomycetes. The combination of IFN-g and GM-CSF showed no better effects than IFN-g or GM-CSF alone in enhancing hyphal damage or O 2 Ϫ production. However, the combination induced differentiation of PMNLs into major histocompatibility complex class II-expressing antigen-presenting cells [55] [56] [57] [58] , enabling them to participate in the subsequent T cell response. Although these results are derived from in vitro models, we suggest that the combination may have therapeutic potential that warrants further evaluation in animal models of zygomycosis. Our study also demonstrated species-specific increases of TNF-a release as a result of treatment with the combination of IFN-g and GM-CSF, in contrast to the decreased IL-8 release from IFN-g-treated PMNLs. These data reflect different immunoregulatory mechanisms in host defenses against each of the 3 zygomycetes. Perhaps the down-regulation of IL-8 expression by IFN-g-treated PMNLs is induced by a negative feedback pathway to modulate the inflammatory response against zygomycetes.
The data provided in this study contribute to a better understanding of the pathogenesis of zygomycosis. Because of the difficulty in treatment and the high mortality of patients with infections caused by zygomycetes, IFN-g and GM-CSF may prove to be useful therapeutic adjuncts. Further investigations in immunocompetent and immunosuppressed animal models (e.g., corticosteroid-treated or NADPH-oxidase-knockout mice) and, ultimately, clinical trials are warranted to assess the utility of IFN-g and GM-CSF as adjuncts to conventional antifungal chemotherapy.
